Application Sponsors
ANDA 203501 | GLENMARK PHARMS LTD | |
Marketing Status
Application Products
001 | CAPSULE, EXTENDED RELEASE;ORAL | 75MG | 0 | INDOMETHACIN | INDOMETHACIN |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2017-06-22 | |
LABELING; Labeling | SUPPL | 3 | AP | 2021-04-28 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
GLENMARK PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 203501
[companyName] => GLENMARK PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"INDOMETHACIN","activeIngredients":"INDOMETHACIN","strength":"75MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/22\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"08\/16\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2019-08-16
)
)